Get started
Author

Mounirou Baby

Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
2008 · Mahamadou A. Thera, Ogobara K. Doumbo, et al. · PLoS ONE · 178
PDF
Genetic Subtypes of HIV Type 1 and HIV Type 2 Strains in Commercial Sex Workers from Bamako, Mali
1998 · MARTINE PEETERS, BRAHIMA KOUMARE, et al. · AIDS Research and Human Retroviruses · 76
Killer Bee Molecules: Antimicrobial Peptides as Effector Molecules to Target Sporogonic Stages of Plasmodium
2013 · Victoria Carter, Ann Underhill, et al. · PLoS Pathogens · 71
PDF
Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians
2007 · Alassane Dicko, David J. Diemert, et al. · PLoS ONE · 65
PDF
Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali
2019 · Aude Jary, Sidi Dienta, et al. · BMC Infectious Diseases · 61
PDF
Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial
2010 · Mahamadou A. Thera, Ogobara K. Doumbo, et al. · PLoS ONE · 57
PDF
Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children
2008 · Alassane Dicko, Issaka Sagara, et al. · PLoS ONE · 48
PDF
Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors
2011 · Claude Tayou Tagny, Maxime Diané Kouao, et al. · Transfusion · 47
PDF
Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
2016 · Mahamadou A. Thera, Drissa Coulibaly, et al. · Malaria Journal · 35
PDF
[Breast cancer: factors influencing the therapeutic itinerary of patients in a medical oncology unit in Bamako (Mali)].
2002 · Madani Ly, Samba Diop, et al. · PubMed · 15
Hemoglobinopathies in the dogon country: Presence of βs, βc, and δa'genes
1994 · Rolande Ducrocq, Mohcine Bennani, et al. · American Journal of Hematology · 9
Genetic polymorphisms with erythrocyte traits in malaria endemic areas of Mali
2019 · Karim Traore, Salimata Konate, et al. · PLoS ONE · 5
PDF
[Quality assurance set-up in a blood transfusion facility: the experience of the National Blood Transfusion Center of Mali].
2010 · Bourèma Kouriba, Amadou Diarra, et al. · PubMed · 3
Le Centre de recherche et de lutte contre la drépanocytose de Bamako : histoire, bilan, défis et perspectives
2021 · Aldiouma Guindo, Yeya Sadio Sarro, et al. · La Presse Médicale Formation · 2
PDF
Blood donation type and hepatitis B and C seroepidemiology at Hôpital Sominé DOLO de Mopti
2020 · Modibo Coulibaly, Bakary Maiga, et al. · GSC Biological and Pharmaceutical Sciences · 2
PDF
Prevalence of red blood cell alloantibodies in pregnant women with sickle cell disease in Bamako
2024 · Minkoro Fomba, Boubacari Toure, et al. · Transfusion Medicine · 1
[The malignant hemopathies in children: epidemiologic aspects in the Haematology and Medical Oncology Ward of Point G Hospital, Bamako, Mali (1996-2003)].
2008 · Dapa Aly Diallo, Mounirou Baby, et al. · PubMed · 1
A Comprehensive Study on the Hematological Progression of Sickle Cell Disease Patients with COVID-19 at the Center for Research and Control of Sickle Cell Disease, Bamako.
2024 · Aldiouma Guindo, Yeya Dit Sadio Sarro, et al. · PubMed
PDF
P-015 Réticence au don de sang au CNTS de Bamako
2023 · Minkoro Fomba, Mounirou Baby, et al. · Transfusion Clinique et Biologique
Motivation au don de sang, Mali
2021 · Minkoro Fomba, Ibrahima Moulaye Diarra, et al. · Transfusion Clinique et Biologique
Sécurité infectieuse : dépistage des infections virales des hépatites B et C chez les donneurs de sang du centre national de transfusion sanguine de Bamako, Mali
2019 · Amadou B. Diarra, Hassana Guitteye, et al. · Transfusion Clinique et Biologique
Évaluation de la prescription et de la satisfaction des besoins en produits sanguins à Bamako, Mali
2017 · Amadou B Diarra, Cheick Hamallah Semega, et al. · Transfusion Clinique et Biologique
MOESM1 of Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
2016 · Mahamadou Thera, Drissa Coulibaly, et al. · Figshare
MOESM3 of Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
2016 · Thera, Mahamadou, Coulibaly, Drissa, et al. · Figshare
MOESM2 of Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
2016 · Thera, Mahamadou, Coulibaly, Drissa, et al. · Figshare
Works count: 37
Citation count: 676
H-index: 10
I10-index: 10
Year
Topic
Type